275 related articles for article (PubMed ID: 6945426)
21. [Enhancement of the activity of hepatitis B virus vaccine by association with murabutide].
Audibert F; Przewlocki G; Lefrancier P; Choay J; Chedid L
C R Seances Acad Sci III; 1982 Nov; 295(10):611-4. PubMed ID: 6218866
[TBL] [Abstract][Full Text] [Related]
22. [Immunoadjuvant activities of bacterial cell wall components--with special reference to the effects of administration with various vehicles].
Kinoshita F
Osaka Daigaku Shigaku Zasshi; 1978 Jun; 23(1):141-57. PubMed ID: 397324
[No Abstract] [Full Text] [Related]
23. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
24. In vivo regulation of humoral and cellular immune responses of mice by a synthetic adjuvant, N-acetyl-muramyl-L-alanyl-D-isoglutamine, muramyl dipeptide for MDP.
Leclerc C; Juy D; Bourgeois E; Chedid L
Cell Immunol; 1979 Jun; 45(1):199-206. PubMed ID: 313275
[No Abstract] [Full Text] [Related]
25. [Antitumor immunoadjuvants of microbial origin: the limitations in the immune system and microbial structure].
Cassone A
Ann Ist Super Sanita; 1982; 18(3):497-500. PubMed ID: 6765082
[No Abstract] [Full Text] [Related]
26. Adjuvant activity of N-acetyl muramyl dipeptides for the induction of delayed-type hypersensitivity to azobenzenearsonate-N-acetyl-L-tyrosine in guinea pigs.
Azuma I; Kamisango KI; Saiki I; Tanio Y; Kobayashi S; Yamamura Y
Infect Immun; 1980 Sep; 29(3):1193-6. PubMed ID: 7429634
[TBL] [Abstract][Full Text] [Related]
27. Immunological adjuvants and their modes of action.
Allison AC
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):141-7. PubMed ID: 9597079
[TBL] [Abstract][Full Text] [Related]
28. [Mechanism of action and clinical effectiveness of immunomodulator glucosaminylmuramyl dipeptide (licopide)].
Ivanov VT; Andronova TM; Nesmeianov VA; Pinegin BV; Ledger P; Bomford R; Khaitov RM
Klin Med (Mosk); 1997; 75(3):11-5. PubMed ID: 9229604
[No Abstract] [Full Text] [Related]
29. Specific impaired alloreactivity of mice immunized with syngeneic MLCT-lymphoblasts using muramylpeptides as adjuvant.
Binz H; Tarcsay L; Wigzell H; Dukor P
Transplant Proc; 1981 Mar; 13(1 Pt 1):566-73. PubMed ID: 6455801
[No Abstract] [Full Text] [Related]
30. [Natural immunostimulants].
Nikitin AV; Navashin SM
Antibiotiki; 1983 Sep; 28(9):702-16. PubMed ID: 6357066
[No Abstract] [Full Text] [Related]
31. Adjuvant activity of synthetic 6-O-"mycoloyl"-N-acetylmuramyl-L-alanyl-D-isoglutamine and related compounds.
Azuma I; Sugimura K; Yamawaki M; Uemiya M; Kusumoto S; Okada S; Shiba T; Yamamura Y
Infect Immun; 1978 Jun; 20(3):600-7. PubMed ID: 97234
[TBL] [Abstract][Full Text] [Related]
32. Muramyl dipeptide stimulation of particle clearance in several animal species.
Waters RV; Ferraresi RW
J Reticuloendothel Soc; 1980 Nov; 28(5):457-71. PubMed ID: 7441647
[No Abstract] [Full Text] [Related]
33. Macrophage-stimulating effect of a synthetic muramyl dipeptide and its adjuvant-active and -inactive analogs for the production of T-cell activating monokines.
Iribe H; Koga T; Onoue K; Kotani S; Kusumoto S; Shiba T
Cell Immunol; 1981 Oct; 64(1):73-83. PubMed ID: 7028277
[No Abstract] [Full Text] [Related]
34. [Changes of the immune status of children with relapsing herpetic stomatitis, suffering from allergic diseases, during licopide treatment].
Kuznetsova OIu; Balabolkin II; Kuznetsova NI
Stomatologiia (Mosk); 2004; 83(3):49-52. PubMed ID: 15159749
[TBL] [Abstract][Full Text] [Related]
35. [Stimulation of the nonspecific resistance by beta-heptylglycoside-muramyldipeptide in mice].
Kaliuzhin OV; Kaliuzhin VV; Zemliakov AE; Elkina SI; Shkalev MV; Sergeev VV
Biull Eksp Biol Med; 1999 May; 127(5):543-5. PubMed ID: 10399577
[No Abstract] [Full Text] [Related]
36. [Stimulation of polymorphonuclear leukocytes by bacterial cell wall components and related synthetic compounds].
Ishihara Y
J Osaka Univ Dent Sch; 1981 Jun; 26(1):105-20. PubMed ID: 6945420
[No Abstract] [Full Text] [Related]
37. Adjuvant activity of nocardomycoloyl derivatives of N-acetylmuramyldipeptide in mice and guinea pigs.
Saiki I; Uemiya M; Kusama T; Yamamura Y; Azuma I
Microbiol Immunol; 1980; 24(3):265-9. PubMed ID: 6968020
[No Abstract] [Full Text] [Related]
38. [What is immunopharmacology?].
Resch K
Dtsch Med Wochenschr; 1983 Feb; 108(5):163-6. PubMed ID: 6600679
[No Abstract] [Full Text] [Related]
39. Comparison of the effects of five adjuvants on the antibody response to influenza virus antigen in guinea pigs.
Robuccio JA; Griffith JW; Chroscinski EA; Cross PJ; Light TE; Lang CM
Lab Anim Sci; 1995 Aug; 45(4):420-6. PubMed ID: 7474883
[TBL] [Abstract][Full Text] [Related]
40. Chemical synthesis and adjuvant activity of N-acetylmuramyl-L-alanyl-D-isoglutamine (MDP) analogs 1, 2.
Kamisango K; Saiki I; Tanio Y; Kobayashi S; Fukuda T; Sekikawa I; Azuma I; Yamamura Y
Chem Pharm Bull (Tokyo); 1981 Jun; 29(6):1644-54. PubMed ID: 7296716
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]